A high antithrombin III result on a blood test usually reflects either a temporary physiological shift, a medication effect, or a lab artifact rather than a dangerous condition on its own. Antithrombin III is a natural blood-thinning protein your liver produces, and while low levels raise serious red flags for clotting disorders, elevated levels get far less clinical attention because they are rarely tied to urgent health threats. That said, a high reading is not meaningless, and understanding why it happens can reveal useful information about your liver, your medications, or even the accuracy of the test itself.
What Antithrombin III Does in Your Blood
Antithrombin III is a protein that circulates in your plasma and acts as a brake on blood clotting. It belongs to a family of proteins called serpins, which are essentially built to shut down the enzymes that form clots. Its main job is inhibiting thrombin, the enzyme at the center of the clotting cascade, but it also blocks several other clotting factors along the way.1Biochimie. Antithrombin III: structural and functional aspects Think of it as one of the body’s built-in safety mechanisms to prevent clots from forming where they should not.
The protein also has anti-inflammatory properties, which means it does more than just manage clotting. During severe infections or widespread inflammation, antithrombin levels can drop sharply because the protein gets consumed faster than the liver can replace it.2PubMed. Antithrombin: anti-inflammatory properties and clinical applications This interplay between clotting and inflammation is one reason doctors track antithrombin levels in critically ill patients, not just in people with clotting concerns.
Common Medical Causes of Elevated Antithrombin III
Most of the clinical literature on antithrombin focuses on deficiency, so data on elevated levels is thinner. Still, several conditions are known to push antithrombin III above the normal reference range, which most labs set around 80 to 120 percent activity.
One well-documented cause is acute viral hepatitis. In a study of patients with hepatitis A, antithrombin activity climbed to roughly 234 percent of normal during acute infection, confirmed by antigen testing at 210 percent. Once the infection resolved, levels returned to the normal range.3PubMed. High plasma antithrombin levels in acute hepatitis A The liver is the organ that manufactures antithrombin, so acute liver inflammation can paradoxically cause a burst of production before the organ gets overwhelmed. This is very different from chronic liver disease, where the liver gradually loses its ability to produce clotting proteins and antithrombin tends to fall instead.
Kidney disease also plays an interesting role. In children with nephrotic syndrome, antithrombin levels tend to drop during active relapse because the protein leaks out through damaged kidneys. But during remission, the liver appears to overcompensate by ramping up production, driving antithrombin levels above normal.4Pathophysiology of Haemostasis and Thrombosis. Antithrombin III (AT III) and Fibrinogen Levels in Nephrotic Syndrome in Children If you are seeing a high antithrombin result while recovering from a kidney flare, this rebound effect is the likely explanation.
Metabolic conditions can contribute too. Research on people with high triglyceride levels found that antithrombin III was elevated in both men and women with hypertriglyceridemia, alongside other clotting-related proteins. These patients also tended to have insulin resistance, glucose intolerance, and elevated blood pressure, suggesting that a high antithrombin result in this context may be part of a broader metabolic picture rather than an isolated finding.5PubMed. Thrombophilia in Patients with Hypertriglyceridemia
Medications and Substances That Raise Levels
Certain drugs can push antithrombin III above the reference range, and this is one of the more common explanations for a high result in otherwise healthy people. Anabolic steroids are the best-studied example. Research going back decades has shown that most 17-alpha-alkylated anabolic steroids raise plasma antithrombin III levels, which is the opposite of what oral contraceptives tend to do.6Thrombosis and Haemostasis. Effect of Anabolic Steroids on Plasma Antithrombin III
More recent work on people using anabolic androgenic steroids confirmed this pattern. Current users showed higher concentrations of antithrombin alongside other natural anticoagulant proteins like protein C and protein S.7PubMed. Procoagulant State in Current and Former Anabolic Androgenic Steroid Abusers If you are using these substances and your blood work shows elevated antithrombin, the connection is fairly well established. It is worth mentioning this to your doctor, especially since steroid users may be reluctant to disclose use.
On the flip side, oral estrogen-based hormone therapy tends to lower antithrombin rather than raise it. Studies in postmenopausal women found that oral conjugated estrogen replacement reduced functional antithrombin III, while transdermal estradiol did not change it.8PubMed. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women A separate randomized trial confirmed that oral estradiol decreased antithrombin activity compared to no treatment, while transdermal delivery had no effect.9PubMed. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women This means that stopping or reducing oral estrogen therapy could, in theory, unmask a shift toward higher antithrombin levels, though this is not well studied on its own.
When a High Reading Is Actually a Lab Artifact
Here is where things get tricky, and where many people with unexpected antithrombin results end up confused. Several widely used anticoagulant medications can falsely inflate antithrombin activity levels on standard lab tests, making it look like you have more antithrombin than you actually do.
The problem depends on which type of test your lab runs and which blood thinner you take. Direct thrombin inhibitors like argatroban, bivalirudin, and dabigatran falsely elevate results on tests that measure antithrombin’s ability to block thrombin (called IIa-based assays), but they do not affect tests that measure its ability to block factor Xa. Meanwhile, factor Xa inhibitors like rivaroxaban, apixaban, and edoxaban falsely elevate Xa-based assay results but leave the thrombin-based results alone.10Journal of Thrombosis and Haemostasis. Recommendations for clinical laboratory testing for antithrombin deficiency If you are on any of these medications and your antithrombin comes back high, the result may simply reflect the drug interfering with the test rather than a genuine elevation in the protein itself.
This matters because millions of people worldwide take direct oral anticoagulants, and antithrombin testing is sometimes ordered without full awareness of the interference issue. If your doctor orders this test while you are on one of these blood thinners, ask whether the lab method used can distinguish a true result from a drug artifact. In some cases, the solution is as simple as running the opposite type of assay.
Why Doctors Pay Far More Attention to Low Antithrombin
If you search for information about antithrombin III, you will notice that almost everything is about deficiency, not elevation. There is a good reason for this imbalance. Inherited antithrombin deficiency carries a dramatically increased risk of venous blood clots, estimated at 5 to 50 times the normal risk depending on the severity. The condition occurs in roughly 0.02 to 0.17 percent of the general population but shows up in about 1 to 5 percent of patients who have already had a blood clot.10Journal of Thrombosis and Haemostasis. Recommendations for clinical laboratory testing for antithrombin deficiency
By contrast, there is no established clinical syndrome associated with having too much antithrombin. In theory, a very high level could mean your blood is slightly harder to clot, which might manifest as easier bruising or prolonged bleeding from minor injuries. But this is not a recognized clinical concern in the way that deficiency is, and no medical guidelines specifically address the management of elevated antithrombin. The test was designed primarily to catch people at risk for clots, and the clinical infrastructure around it reflects that focus.
When patients with severe sepsis and disseminated intravascular coagulation are treated with antithrombin concentrate, the goal is usually to bring their levels up from dangerously low values. In one study of sepsis patients receiving antithrombin supplementation, survivors saw their activity rise above 80 percent by day three, while non-survivors failed to reach that threshold.11PubMed Central. The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation Even in therapeutic settings where antithrombin is deliberately given as a drug, the target range is 80 to 120 percent of normal, and doses are calibrated to avoid pushing levels much beyond that.12Blood. Prospective, Phase III Study of the Efficacy, Safety, and Pharmacokinetics of a Human Antithrombin III Concentrate in Congenital Antithrombin Deficiency during Surgery or Childbirth The cautious approach to dosing tells you something about how clinicians view overshoot: they do not consider it safe to let levels climb unchecked, even if the consequences of mild elevation are not well characterized.
How Antithrombin Testing Works
Understanding how the test is run can help you make sense of your result. There are two broad categories of antithrombin tests. Functional assays measure how well the protein actually inhibits clotting enzymes. Immunological assays measure how much of the protein is physically present in your blood, regardless of whether it works properly. The two do not always agree.13PubMed. Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms
Most labs start with a functional assay, since it captures both quantity problems and quality problems. If the functional result is abnormal, an immunological assay may follow to distinguish between the two. For the chromogenic functional tests that most modern labs use, results correlate well with older immunological methods, with correlation coefficients above 0.94 in validation studies.14American Journal of Clinical Pathology. Measurement of Antithrombin III in Normal and Pathologic States Using Chromogenic Substrate S-2238
If your result is high, it is worth asking your doctor whether the lab ran a functional or immunological test, and whether any medications you are taking could interfere with the method used. A single elevated reading is rarely enough to draw conclusions on its own. Retesting after addressing potential confounders, like stopping a medication or waiting for an acute illness to resolve, is often the most practical next step.
Antithrombin Levels During Pregnancy
Pregnancy is one of the most common reasons antithrombin gets tested, because pregnant women face heightened clot risk and doctors want to understand their baseline coagulation profile. Interestingly, the research on what pregnancy does to antithrombin levels is somewhat contradictory.
One study that tracked antithrombin throughout pregnancy and after delivery found that levels were about 20 percent lower than baseline during pregnancy overall, with a further 13 percent drop between midtrimester and delivery. Immediately after childbirth, levels plunged to about 30 percent below baseline before recovering over the next 72 hours.15PubMed. Characterization of antithrombin levels in pregnancy This postpartum dip is worth knowing about: if antithrombin is tested in the first day or two after delivery, the result may look worryingly low without actually reflecting a permanent deficiency.
Another study found that antithrombin levels remained largely within normal non-pregnant reference ranges throughout pregnancy, delivery, and the postpartum period.16PubMed. Haemostatic reference intervals in pregnancy The discrepancy may come down to differences in study design, timing of blood draws, and whether absolute values or relative changes were being measured. The practical takeaway is that pregnancy generally pushes antithrombin down, not up. If you are pregnant and your antithrombin is elevated, pregnancy itself is unlikely to be the explanation, and your doctor may look harder at other causes.
Genetic Variants That Standard Tests Miss
One complication in interpreting any antithrombin result, whether high, low, or normal, is that some genetic variants of the protein can fly under the radar of routine lab work. The antithrombin A384S mutation, also called Antithrombin Cambridge II, is a striking example. This variant does not significantly affect antithrombin antigen levels or the commonly used anti-Xa functional assay, and it only slightly reduces anti-thrombin activity. Routine clinical methods cannot reliably detect it.17Blood. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis
Despite being invisible to standard tests, this mutation carries real clinical weight. In a large case-control study of over 1,000 Spanish patients with venous blood clots, carriers of the A384S variant had roughly a tenfold increased risk of venous thrombosis compared to non-carriers. The mutation was found in about 1.7 percent of patients with clots but only 0.2 percent of healthy controls, making it the single most common cause of antithrombin-related thrombotic problems in the population studied.17Blood. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis
The relevance to a high antithrombin reading is indirect but important. If your antithrombin levels test high or normal, that result does not rule out every antithrombin abnormality. Someone with a variant like A384S could have a completely normal-looking lab panel and still carry significant clotting risk. Genetic testing can identify these variants, but it is typically reserved for patients with a strong personal or family history of unexplained blood clots. If your doctor is investigating your clotting risk and the standard antithrombin test comes back normal or elevated, and yet you have had clotting events that do not add up, specialized molecular testing may be the next step worth discussing.